PharmTech News

Melanie Sena is community editor of Pharmaceutical Technology.

Articles

Bristol-Myers Squibb Company and Samsung BioLogics announced the companies have entered into a 10-year agreement.

Bristol-Myers Squibb and Samsung BioLogics Announce Biopharmaceutical Manufacturing Relationship

Wyeth Pharmaceuticals has agreed to pay $490.9 million to resolve its criminal and civil liability arising from the unlawful marketing of the prescription drug Rapamune for uses not approved as safe and effective by FDA.

Wyeth Fined $490.9 Million for Unlawful Marketing of Rapamune

Kemwell Biopharma announced that it has acquired Cirrus Pharmaceuticals Inc., a contract development services company based in Research Triangle Park, N.C.

Kemwell Biopharma Acquires Cirrus Pharmaceuticals Inc.

A roundup of developments in global health and sustainability from the bio/pharmaceutical industry, its suppliers, and other public and private organizations.

Pharma News in Global Health and Sustainability

Research will focus on cancer and viral disease targets not addressable using antibody-based technologies.

Immunocore Collaborates with GlaxoSmithKline on T-Cell Receptor Technology

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

Highlights from the 66th World Health Assembly and the pharmaceutical industry?s role in addressing noncommunicable diseases, mental and neurological disorders, R&D for diseases of the developing world, counterfeit medicines, the global vaccine action plan, and neglected tropical diseases.

Pharma Industry Participates in Global Health Initiatives

The agreement is worth up to $552 million, depending on meeting set milestones.

MorphoSys and GSK Partner in Antibody Pact

Sanofi Ends Development of Two Phase III Drugs

Unither Pharmaceuticals will acquire an UCB Rochester, NY pharmaceutical plant used to liquid pharmaceutical products.

Bio/Pharma News